Skip to main content

Bruker Warns Analysts of Single-Digit Q1 Revenue Decline

Premium

The story originally ran on April 17.

Bruker said last week that it expects revenues for the first quarter of 2009 to decline in the single digits. Adjusted for the effects of foreign exchange, revenues are expected to increase in the low single digits.

Bruker officials offered the glimpse into the company's preliminary Q1 results during a presentation made to analysts that was filed with the US Securities and Exchange Commission. The company has not yet scheduled its earnings release for the first quarter but is expected to announce results early next month.

During the presentation, company officials also said that as a result of cost-reduction moves, Bruker expects to achieve savings of about $15 million this year. Steps the firm has taken since the summer include reductions in the salaries of top management [See PM 04/16/09] and layoffs in the US and parts of Europe.

Last month, during a conference call to discuss its 2008 fourth quarter and full-year earnings, company CFO William Knight said that the global economy continued to tank in January and February and forecast currency-adjusted low single-digit percentage decline in revenue or flat revenue for full-year 2009.

During the first quarter of 2008, Bruker's revenues rose 15 percent to $238.4 million over Q1 2007 revenues of $207.5 million.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.